{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T07:14:03Z","timestamp":1696662843179},"reference-count":9,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T00:00:00Z","timestamp":1383782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Cytopathology"],"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:p>A genetic link between cutaneous melanoma and thyroid cancer (TC) has been identified. A high percentage of both melanomas and papillary carcinomas of the thyroid harbors a recurrent mutation (i.e., BRAF<jats:sup>V600E<\/jats:sup>) in the <jats:italic>BRAF<\/jats:italic> oncogene. Herein, we report the case of a 65\u2010year\u2010old man with papillary TC and cutaneous malignant melanoma metastatic to masseter muscle, both characterized by <jats:italic>BRAF<\/jats:italic> mutation. This is one of the rare reports in which a complete molecular characterization has been performed. As the patients with papillary thyroid carcinoma have a higher risk of malignant melanoma and vice versa, continuous monitoring of such patients, with either of these tumors is necessary. Fine\u2010needle aspiration cytology is useful as shown in the present case. Diagn. Cytopathol. 2014;42:877\u2013879. \u00a9 Wiley Periodicals, Inc.<\/jats:p>","DOI":"10.1002\/dc.23060","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T07:46:05Z","timestamp":1410939965000},"page":"877-879","source":"Crossref","is-referenced-by-count":3,"title":["Detection of BRAFV600E mutation on papillary thyroid carcinoma and metastatic malignant melanoma by fine\u2010needle aspiration cytology"],"prefix":"10.1002","volume":"42","author":[{"given":"Bruno Jim","family":"Rocca","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology Section of Pathology University of Siena  Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Raffaella","family":"Ambrosio","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology Section of Pathology University of Siena  Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Ginori","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology Section of Pathology University of Siena  Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Disanto","sequence":"additional","affiliation":[{"name":"Unit of Pathology Azienda Ospedaliera Universitaria Senese Siena Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,7]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2010.22.3.370"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1426"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21300"},{"key":"e_1_2_5_5_1","first-page":"1454","article-title":"High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC\u2010RAS\u2010BRAF signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura ET","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.01239"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0368"},{"key":"e_1_2_5_8_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D33RN7K0D8","article-title":"High prevalence of hypothyroidism in male patients with cutaneous melanoma","volume":"12","author":"Shah M","year":"2006","journal-title":"Dermatol Online J"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206706"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.8.625"}],"container-title":["Diagnostic Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fdc.23060","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dc.23060","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:29:30Z","timestamp":1696580970000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/dc.23060"}},"subtitle":["How Genetic Testing May Drive Toward Personalized Medicine"],"short-title":[],"issued":{"date-parts":[[2013,11,7]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1002\/dc.23060"],"URL":"https:\/\/doi.org\/10.1002\/dc.23060","archive":["Portico"],"relation":{},"ISSN":["8755-1039","1097-0339"],"issn-type":[{"value":"8755-1039","type":"print"},{"value":"1097-0339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,7]]}}}